Literature DB >> 1569962

The limits of the cellular capacity to mediate an estrogen response.

P Webb1, G N Lopez, G L Greene, J D Baxter, P J Kushner.   

Abstract

While steroid response is generally restricted by the availability of steroid receptors, the theoretical limits of the response are not known. We have constructed a series of cell lines that stably express the estrogen receptor (ER) at levels up to 5,000,000 ERs per cell and employed these cells to explore the limits of the estrogen response. Several reporter genes with estrogen response elements upstream of the herpes thymidine kinase promoter showed hyperbolic saturation kinetics with increasing ER. Maximum response was 10 times that seen in cell lines with receptor titers comparable to physiological levels. Half-maximal responses required 500,000 receptors per cell, and cells with 5,000,000 ERs showed greater than 90% maximum induction. Estradiol dose-response studies indicated that the receptors are limiting below 500,000 ERs per cell, but at higher ER titers there are spare receptors. In contrast to most reporters, the widely used reporter pA2-CAT, which has 200 base pairs of Xenopus vitellogenin DNA between the response element and the promoter, showed squelching at ER levels beyond 500,000 per cell. Cell lines that expressed ER above this level activated pA2-CAT with a distorted hormone dependence, where saturating ligand concentrations were inhibitory. All reporters displayed squelching when the ER was provided by transient transfection at a level that we judge is 20,000,000 per cell by extrapolation from the behavior of stable cell lines. These findings suggest that saturation of the cellular capacity to mediate an estrogen response and ER-dependent squelching occur at receptor titers well above those encountered in nature. If current models of steroid hormone action are correct, the findings also imply that estrogen response elements are occupied to very small extents under normal conditions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569962     DOI: 10.1210/mend.6.2.1569962

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  23 in total

Review 1.  Intrinsic and Extrinsic Factors Governing the Transcriptional Regulation of ESR1.

Authors:  David K Lung; Rebecca M Reese; Elaine T Alarid
Journal:  Horm Cancer       Date:  2020-06-26       Impact factor: 3.869

2.  Specific adaptations of estrogen receptor alpha and beta transcripts in liver and heart after endurance training in rats.

Authors:  Amélie Paquette; Dongaho Wang; Marie-Soleil Gauthier; Denis Prud'homme; Marek Jankowski; Jolanta Gutkowska; Jean-Marc Lavoie
Journal:  Mol Cell Biochem       Date:  2007-08-01       Impact factor: 3.396

3.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

Authors:  M D Mueller; J L Vigne; A Minchenko; D I Lebovic; D C Leitman; R N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Estrogen-related abnormalities in glomerulosclerosis-prone mice: reduced mesangial cell estrogen receptor expression and prosclerotic response to estrogens.

Authors:  Mylène Potier; Michael Karl; Feng Zheng; Sharon J Elliot; Gary E Striker; Liliane J Striker
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

5.  Mutations in the conserved C-terminal sequence in thyroid hormone receptor dissociate hormone-dependent activation from interference with AP-1 activity.

Authors:  F Saatcioglu; G Lopez; B L West; E Zandi; W Feng; H Lu; A Esmaili; J W Apriletti; P J Kushner; J D Baxter; M Karin
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

6.  Subtype-specific estrogen receptor-mediated vasodilator activity in the cephalic, thoracic, and abdominal vasculature of female rat.

Authors:  Ossama M Reslan; Zongzhi Yin; Graciliano R A do Nascimento; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2013-07       Impact factor: 3.105

7.  Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.

Authors:  Nicholas B Berry; Meiyun Fan; Kenneth P Nephew
Journal:  Mol Endocrinol       Date:  2008-04-03

8.  Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.

Authors:  Lorin M Henrich; Jeffrey A Smith; Danielle Kitt; Timothy M Errington; Binh Nguyen; Abdulmaged M Traish; Deborah A Lannigan
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

Review 9.  Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease.

Authors:  Milos Cekic; Iqbal Sayeed; Donald G Stein
Journal:  Front Neuroendocrinol       Date:  2009-04-24       Impact factor: 8.606

10.  Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site.

Authors:  G Lopez; F Schaufele; P Webb; J M Holloway; J D Baxter; P J Kushner
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.